Latest News

Image description

FDA OKs Baraclude generic from Aurobindo

Aurobindo Pharma Limited announced Thursday that it had received approval from the Food and Drug Administration for its entecavir tablets in 0.5- and 1-mg dosage strengths. 

Image description

Pharmacy headwinds impact Fred’s Q2

For the second quarter Fred's net loss totaled $4.9 million or ($0.13) per share. This compares with a net loss of $16.4 million or ($0.45) per share for the second quarter ended Aug. 2, 2014.